The intrahepatic tumor number, macrovascular invasion, Barcelona Clinic Liver Cancer (BCLC) stage, NLR, CRP level, and prior ATB were identified as significant predictors associated with the PFS based on mRECIST. The gene discussed is CRP; the disease is neoplasm.